| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Gilead Sciences, Inc.'s insiders have reduced their positions by a net 15,000 shares worth roughly $2.0M.
GILD sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 92.1K | $12.74M | - | |
| Other | 46.6K | $6.45M | - | |
| Other | 27.9K | $3.85M | - | |
| CFO | 27.9K | $3.85M | - | |
| VP | 20.0K | $2.77M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2017 | Martin John C | Executive Chairman | Sale+OE | 73,333 | $82.56 | $6,054,319.49 | -1.2% | |
| Sep 7, 2017 | Washington Robin L | EVP, CFO | Sale+OE | 51,820 | $85.00 | $4,404,700.00 | -31.4% | |
| Sep 1, 2017 | Alton Gregg H | EVP Comm&Acs Ala, Corp&Med Aff | Sale+OE | 25,000 | $83.05 | $2,076,187.90 | -13.8% | |
| Sep 1, 2017 | Martin John C | Executive Chairman | Sale+OE | 73,333 | $83.11 | $6,094,991.81 | -1.2% | |
| Aug 31, 2017 | Meyers James R | EVP Worldwide Commercial Ops | Sale+OE | 60,000 | $83.19 | $4,991,289.50 | -73.1% | |
| Aug 30, 2017 | Alton Gregg H | EVP Comm&Acs Ala, Corp&Med Aff | Sale+OE | 50,000 | $79.00 | $3,950,000.00 | -37.2% | |
| Aug 1, 2017 | Alton Gregg H | EVP Comm&Acs Ala, Corp&Med Aff | Sale+OE | 15,000 | $75.88 | $1,138,189.50 | -14.1% | |
| Aug 1, 2017 | Martin John C | Executive Chairman | Sale+OE | 73,333 | $75.86 | $5,562,777.38 | -2.3% | |
| Jul 21, 2017 | Alton Gregg H | EVP Comm&Acs Ala, Corp&Med Aff | Sale+OE | 40,000 | $74.00 | $2,960,000.00 | -16.6% | |
| Jul 3, 2017 | Martin John C | Executive Chairman | Sale+OE | 73,333 | $71.00 | $5,206,892.33 | -2.3% |